Zydus Lifesciences To Pay $120 Million To Astellas To Settle Patent Litigation

Zydus Pharmaceuticals USA, Inc USA, a wholly owned subsidiary of the company, has entered into a settlement agreement with Astellas in relation to its drug Myrbetriq.

from NDTV Profit - Latest https://ift.tt/JWlBT1a
Zydus Pharmaceuticals USA, Inc USA, a wholly owned subsidiary of the company, has entered into a settlement agreement with Astellas in relation to its drug Myrbetriq.

Comments

Post a Comment

Popular posts from this blog

RBI Vs Government: Finance Ministry To Shortly Issue A Statement

The government has invoked never-before-used powers under the RBI Act that allow it to issue directions to the central bank governor on matters of public interest. from NDTV Profit - Latest https://ift.tt/2P1gEl5 The government has invoked never-before-used powers under the RBI Act that allow it to issue directions to the central bank governor on matters of public interest.
Read more

भारत-चीन की लड़ाई पहुंची बंदरगाहों पर! चीनी समान की हो रही है बारीकी से जांच

Image
India-China Standoff: पिछले कुछ दिनों से चेन्नई और मुंबई के पोर्ट पर चीन से आने वाले समानों की बारीकी से जांच हो रही है. लेकिन इसके पीछे कोई ठोस वजह नहीं बताई गई है. from Latest News चीन News18 हिंदी https://ift.tt/2Yz8FyY
Read more